Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide

Cancer

Volumn 86, Issue 7, 1999, Pages 1322-1328

  Hoskin, Peter J ^a   Saunders, Michelle I ^a   Dische, Stanley ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Bladder carcinoma; Carbogen; Hyperbaric oxygen; Misonidazole; Nicotinamide; Radiotherapy

Indexed keywords

CARBOGEN; MISONIDAZOLE; NICOTINAMIDE; RADIOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERBARIC OXYGEN; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CARBON DIOXIDE; HUMANS; HYPERBARIC OXYGENATION; MIDDLE AGED; MISONIDAZOLE; NIACINAMIDE; OXYGEN; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; URINARY BLADDER NEOPLASMS;

EID: 0033214120     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991001)86:7<1322::AID-CNCR30>3.0.CO;2-E     Document Type: Article

References (17)

1. Duncan W, Quilty PM. The results of a series of 963 patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage x-ray therapy. Radiother Oncol 1986;7:299-310.
2. Gospodarowicz MK, Rider W, Keen CW, Connolly JG, Jewett MAS, Cummings BJ, et al. Bladder cancer: long term follow-up results of patients treated with radical radiation. Clin Oncol (R Coll Radiol) 1991;3:155-61.
3. Jahnson S, Pedersen J, Westman G. Bladder cancer: a 20 year review of radical irradiation therapy. Radiother Oncol 1991; 22:111-7.
4. Rew DA, Thomas DJ, Coptcoat M, Wilson GD. Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry Br J Urol 1991;68:44-8.
5. Maciewjewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991;21:163-70.
6. De Neve W, Lybeert MLM, Goor C, Crommelin MA, Ribot JG. Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother Oncol 1995; 36:183-8.
7. Edsmyr F, Andersson L, Esposti PL, Littbrand B, Nilsson B. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 1985;4:197-203.
8. Overgaard J. Modification of hypoxia: from Gottwald Schwarz to nicotinamide: have we learned the lesson? In: Kogelnik HD, editor. Progress in radiology. Volume 5. Bologna, Italy: Monduzzi Editore, 1995:469-75.
9. Cade IS, McEwan JB, Dische S, Saunders MI, Watson ER, Halnan KE, et al. Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the bladder. Br J Radiol 1978;51:876-8.
10. Hoskin PJ, Saunders MI, Phillips H, Cladd H, Powell MEB, Goodchild K, et al. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy. Br J Cancer 1997;76:260-3.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Dische S, Warburton MF, Jones D, Lartigau E. The recording of morbidity related to radiotherapy. Radiother Oncol 1989; 16:103-8.
13. Saunders M, Dische S. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide. Br J Cancer 1996;74: (Suppl 27) S271-8.
14. Hope-Stone HF, Blandy JP, Oliver RTD, England H. Radical radiotherapy and salvage cystectomy in the treatment of invasive carcinoma of the bladder. In: Oliver RTD, Hendry WF, Bloom HJG, editors. Bladder cancer: principles of combination therapy. London: Butterworths, 1981:127-36.
15. Powell MEB, Hill SA, Saunders MI, Hoskin PJ, Chaplin DJ. Human tumour blood flow is enhanced by nicotinamide and carbogen breathing. Cancer Res 1997;57:5261-4.
16. Dobbs HJ, Parker RP, Hodson NJ, Husband JE. The use of CT in radiotherapy treatment planning. Radiother Oncol 1983; 1:133-41.
17. Warde P, Gospodarowicz MK. New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder. World J Urol 1997;15:125-33.